Alnylam price target raised to $298 from $275 at Raymond James

Raymond James analyst Gary Nachman raised the firm’s price target on Alnylam (ALNY) to $298 from $275 and keeps an Outperform rating on the shares. Alnylam’s Q3 results were mixed on certain items, but directionally positive overall, and while the top-line slightly missed on lower collaboration revenue, product revenue beat with continued growth for Amvuttra in ATTR-PN, and also with help from solid performance in the Rare franchise, the analyst tells investors in a research note.